Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? No
- 1 April 2003
- journal article
- review article
- Published by Wiley in Journal of Thrombosis and Haemostasis
- Vol. 1 (4) , 632-634
- https://doi.org/10.1046/j.1538-7836.2003.00170.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Plasma therapy in von Willebrand factor protease deficiencyPediatric Nephrology, 2002
- von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndromeBlood, 2002
- Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpuraKidney International, 2001
- Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving proteaseBest Practice & Research Clinical Haematology, 2001
- Total deficiency of specific von Willebrand factor-cleaving protease and recovery following plasma therapy in one patient with hemolytic-uremic syndromeThe Hematology Journal, 2001
- von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic SyndromeNew England Journal of Medicine, 1998
- Haemolytic-uraemic syndrome: basic scienceThe Lancet, 1994
- HUS and TTP: Variable expression of a single entityKidney International, 1987
- Decreased Cold-Insoluble Globulin in Congenital Thrombocytopenia (Upshaw-Schulman Syndrome)New England Journal of Medicine, 1979
- The Hemolytic-Uremic SyndromeNephron, 1973